Adverum Biotechnologies
ADVM
ADVM
113 hedge funds and large institutions have $642M invested in Adverum Biotechnologies in 2015 Q1 according to their latest regulatory filings, with 45 funds opening new positions, 37 increasing their positions, 22 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
11% less capital invested
Capital invested by funds: $719M → $642M (-$76.8M)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Holders
113
Holding in Top 10
2
Calls
$13.4M
Puts
$4.33M
Top Buyers
| 1 | +$20.4M | |
| 2 | +$15.8M | |
| 3 | +$15.4M | |
| 4 |
RIM
RS Investment Management
San Francisco,
California
|
+$13.8M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$12.5M |
Top Sellers
| 1 | -$35.1M | |
| 2 | -$20.2M | |
| 3 | -$13.4M | |
| 4 |
RG
Redmile Group
San Francisco,
California
|
-$11.3M |
| 5 |
Goldman Sachs
New York
|
-$9.5M |